JP2010514681A5 - - Google Patents

Download PDF

Info

Publication number
JP2010514681A5
JP2010514681A5 JP2009543158A JP2009543158A JP2010514681A5 JP 2010514681 A5 JP2010514681 A5 JP 2010514681A5 JP 2009543158 A JP2009543158 A JP 2009543158A JP 2009543158 A JP2009543158 A JP 2009543158A JP 2010514681 A5 JP2010514681 A5 JP 2010514681A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
phenyl
ring
heterocycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009543158A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010514681A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/088032 external-priority patent/WO2008079836A2/en
Publication of JP2010514681A publication Critical patent/JP2010514681A/ja
Publication of JP2010514681A5 publication Critical patent/JP2010514681A5/ja
Withdrawn legal-status Critical Current

Links

JP2009543158A 2006-12-20 2007-12-19 抗凝血剤として有用な大環状第viia因子阻害剤 Withdrawn JP2010514681A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87086406P 2006-12-20 2006-12-20
US98446007P 2007-11-01 2007-11-01
PCT/US2007/088032 WO2008079836A2 (en) 2006-12-20 2007-12-19 Macrocyclic factor viia inhibitors useful as anticoagulants

Publications (2)

Publication Number Publication Date
JP2010514681A JP2010514681A (ja) 2010-05-06
JP2010514681A5 true JP2010514681A5 (https=) 2010-09-16

Family

ID=39430763

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009543158A Withdrawn JP2010514681A (ja) 2006-12-20 2007-12-19 抗凝血剤として有用な大環状第viia因子阻害剤

Country Status (12)

Country Link
US (1) US8420830B2 (https=)
EP (1) EP2102176A2 (https=)
JP (1) JP2010514681A (https=)
AR (1) AR064471A1 (https=)
AU (1) AU2007337025A1 (https=)
CA (1) CA2673598A1 (https=)
CL (1) CL2007003718A1 (https=)
MX (1) MX2009006689A (https=)
NO (1) NO20092279L (https=)
PE (1) PE20081775A1 (https=)
TW (1) TW200836735A (https=)
WO (1) WO2008079836A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008079759A1 (en) 2006-12-20 2008-07-03 Bristol-Myers Squibb Company Bicyclic lactam factor viia inhibitors useful as anticoagulants
CA2782384A1 (en) * 2009-12-08 2011-06-16 Boehringer Ingelheim International Gmbh Process for synthesis of intermediates useful for making substituted indazole and azaindazole compounds
ES2674745T3 (es) * 2010-02-11 2018-07-03 Bristol-Myers Squibb Company Macrociclos como inhibidores del factor XIa
CN102993065B (zh) * 2011-09-13 2015-07-29 中国科学院上海药物研究所 含手性叔丁基亚磺酰基的α-芳基氨基酸酯类化合物、其制备方法及用途
KR101937514B1 (ko) 2011-10-14 2019-01-10 브리스톨-마이어스 스큅 컴퍼니 인자 xia 억제제로서의 치환된 테트라히드로이소퀴놀린 화합물
MX353024B (es) * 2011-12-27 2017-12-18 Bio Pharm Solutions Co Ltd Compuestos de fenil carbamato para uso en la prevencion o tratamiento de epilepsia.
EP2858977A1 (en) 2012-06-08 2015-04-15 Bristol-Myers Squibb Company Macrocyclic factor viia inhibitors
KR20150038369A (ko) * 2012-08-03 2015-04-08 브리스톨-마이어스 스큅 컴퍼니 인자 XIa 억제제로서의 디히드로피리돈 P1
MX361759B (es) * 2012-08-03 2018-12-17 Bristol Myers Squibb Co Compuestos macrocíclicos de dihidropiridona como inhibidores del factor xia y el uso de los mismos en el tratamiento de un trastorno tromboembólico.
TR201807316T4 (tr) 2012-10-12 2018-06-21 Bristol Myers Squibb Co Bir faktör XIa inhibitörünün kristalli formları.
WO2014059214A1 (en) 2012-10-12 2014-04-17 Bristol-Myers Squibb Company Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitors
EP2906552B1 (en) 2012-10-12 2017-11-22 Bristol-Myers Squibb Company Guanidine substituted tetrahydroisoquinoline compounds as factor xia inhibitors
ES2712699T3 (es) 2013-03-25 2019-05-14 Bristol Myers Squibb Co Tetrahidroisoquinolinas que contienen azoles sustituidos como inhibidores del factor XIa
EP3008052A1 (en) * 2013-06-13 2016-04-20 Bristol-Myers Squibb Company Macrocyclic factor viia inhibitors
CN116987080A (zh) 2014-01-31 2023-11-03 百时美施贵宝公司 作为因子xia抑制剂的具有杂环p2′基团的大环化合物
NO2760821T3 (https=) 2014-01-31 2018-03-10
CN107074821B (zh) 2014-09-04 2020-05-22 百时美施贵宝公司 为fxia抑制剂的二酰胺大环化合物
US9453018B2 (en) 2014-10-01 2016-09-27 Bristol-Myers Squibb Company Pyrimidinones as factor XIa inhibitors
EP3072943B1 (en) 2015-03-26 2018-05-02 Idemitsu Kosan Co., Ltd. Dibenzofuran/carbazole-substituted benzonitriles
ES2871111T3 (es) * 2015-07-29 2021-10-28 Bristol Myers Squibb Co Inhibidores macrocíclicos del factor XIa que contienen un grupo P2' no aromático

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3065190D1 (en) 1979-11-05 1983-11-10 Beecham Group Plc Enzyme derivatives, and their preparation
US5023236A (en) 1988-04-07 1991-06-11 Corvas, Inc. Factor VII/VIIA active site inhibitors
US5843442A (en) 1990-10-22 1998-12-01 Corvas International, Inc. Blood coagulation protein antagonists and uses therefor
US5866542A (en) 1994-10-18 1999-02-02 Corvas International, Inc. Nematode-extracted anticoagulant protein
PE121699A1 (es) 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
ZA985247B (en) 1997-06-19 1999-12-17 Du Pont Merck Pharma Guanidine mimics as factor Xa inhibitors.
EP1192135A2 (en) 1999-06-14 2002-04-03 Eli Lilly And Company Serine protease inhibitors
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
US6642252B2 (en) 2000-11-07 2003-11-04 Bristol-Myers Squibb Company Acid derivatives useful as serine protease inhibitors
AR035216A1 (es) 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
WO2003011222A2 (en) * 2001-07-27 2003-02-13 Merck & Co., Inc. Thrombin inhibitors
CA2461202C (en) 2001-09-21 2011-07-12 Donald Pinto Lactam-containing compounds and derivatives thereof as factor xa inhibitors
WO2004072102A2 (en) 2003-02-11 2004-08-26 Bristol-Myers Squibb Company Benzene acetamide compounds useful as serine protease inhibitors
EP1594505A4 (en) 2003-02-11 2008-08-13 Bristol Myers Squibb Co PHENYLGLYCIN DERIVATIVES USEFUL AS SERINE PROTEASE INHIBITORS
PE20061117A1 (es) 2005-01-10 2006-10-13 Bristol Myers Squibb Co DERIVADOS DE FENILGLICINAMIDA COMO INHIBIDORES DEL FACTOR VIIa
CA2600745A1 (en) * 2005-03-03 2006-09-08 The Burnham Institute For Medical Research Screening methods for protein kinase b inhibitors employing virtual docking approaches and compounds and compositions discovered thereby
WO2007002313A2 (en) 2005-06-24 2007-01-04 Bristol-Myers Squibb Company Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants
AR058380A1 (es) 2005-12-23 2008-01-30 Bristol Myers Squibb Co Inhibidores del factor viia macrociclicos utiles como anticoagulantes
US8044242B2 (en) 2006-03-09 2011-10-25 Bristol-Myers Squibb Company 2-(aryloxy) acetamide factor VIIa inhibitors useful as anticoagulants
WO2008079759A1 (en) 2006-12-20 2008-07-03 Bristol-Myers Squibb Company Bicyclic lactam factor viia inhibitors useful as anticoagulants

Similar Documents

Publication Publication Date Title
JP2010514681A5 (https=)
JP2014532070A5 (https=)
JP2014530240A5 (https=)
JP2010529991A5 (https=)
JP2015511629A5 (https=)
JP2021119196A5 (https=)
JP2021511360A5 (https=)
JP2009534404A5 (https=)
JP2021088610A5 (https=)
JP2019034943A5 (https=)
JP2005504789A5 (https=)
JP2017504642A5 (https=)
JPWO2019148044A5 (https=)
JP2010513304A5 (https=)
JP2021501220A5 (https=)
JP2019534260A5 (https=)
JP2012529535A5 (https=)
JP2007513969A5 (https=)
JP2009545611A5 (https=)
JP2017525757A5 (https=)
JP2004504301A5 (https=)
MXPA03011629A (es) Derivado de fenilpiridincarbonilpiperazina.
JPWO2019143678A5 (https=)
JP2012505234A5 (https=)
JP2006508935A5 (https=)